PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

Direct Investments | 13th December, 2017
PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
Direct Investments | 13th December, 2017
Mercia invests £3.5million as part of a £5.0million syndicated investment into Intechnica
Mercia EIS Funds | 11th December, 2017
Games firm nets £600k funding from Mercia for fantasy football app
Direct Investments | 11th December, 2017
Mercia invests £2.5m as part of £3.8m funding round in Medherant
Direct Investments | 8th December, 2017
Mercia announces first closing of EV Growth II
Direct Investments | 6th December, 2017
Half Year Results 2017: “Growth is the central theme throughout these interim results.”
Direct Investments | 5th December, 2017
Mercia appoints new Head of Software & the Internet
Mercia EIS Funds | 5th December, 2017
Mercia Fund Managers wins Best Single Sector Award at Tax Efficiency Awards
NPIF Equity | 30th November, 2017
Industry defining AI start-up secures initial £1.3m to create self-learning machines
Mercia EIS Funds | 29th November, 2017
Video firm focuses on global growth with funding boost from Mercia